source
- AstraZeneca taps Oracle to help improve recruitment for clinical trialsAstraZeneca has turned to data giant Oracle as the U.K.-based Big Pharma works on one of the eternal problems of drug development—improving patient recruitment.Fierce Biotech · 4h ago↗ source
- Merck KGaA to acquire Silence Therapeutics for $1.3 billion, expanding siRNA portfolioMerck KGaA, the German science and technology conglomerate, announced an agreement to purchase UK‑based Silence Therapeutics. The deal is valued at about $1.3 billion and gives Merck access to Sil…